Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Leiomyoma

Cancer Genetics and Cytogenetics

Volumn 158, Issue 1, 2005, Pages 1-26

  Sandberg, Avery A ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN E; DEATH ASSOCIATED PROTEIN KINASE; KI 67 ANTIGEN; PROTEIN MDM2; PROTEIN P53; STEM CELL FACTOR; STEROID RECEPTOR; TELOMERASE;

BONE TUMOR; CENTROMERE; CHROMOSOME 14; CHROMOSOME 7; CYTOGENETICS; DNA BINDING; ESTROGEN ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; LEIOMYOMA; LEIOMYOMATOSIS; MOLECULAR GENETICS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SOFT TISSUE TUMOR; WESTERN BLOTTING; X CHROMOSOME INACTIVATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DISEASE COURSE; GENE LOCATION; GENE MUTATION; GENETIC CODE; KARYOTYPE; LEIOMYOSARCOMA; MICROSATELLITE INSTABILITY; MOLECULAR DYNAMICS; MOSAICISM; PLOIDY; TRISOMY 8;

BONE NEOPLASMS; CHROMOSOME ABERRATIONS; CYTOGENETICS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEIOMYOSARCOMA; MALE; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; UTERINE NEOPLASMS;

EID: 14844356480     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.08.025     Document Type: Article

References (328)

1. S.F. Cramer, and A. Patel The frequency of uterine leiomyomas Am J Clin Pathol 94 1990 435 438
2. R.S. Cotran, V. Kumar, and S.L. Robbins Robbins Pathologic basis of disease 1989 WB Saunders Co Philadelphia
3. M.D. Greenberg, and T.I.G. Kazamel Medical and socioeconomic impact of uterine fibroids Obstet Gynecol Clin North Am 22 1995 625 636
4. S.D. Billings, A.L. Folpe, and S.W. Weiss Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes Am J Surg Pathol 25 2001 1134 1142
5. M. Miettinen Diagnostic soft tissue pathology 2003 Churchill Livingstone New York pp.241-9
6. C. Zaloudek, and H.J. Norris Mesenchymal tumors of the uterus R.J. Kurman Blaustein's pathology of the female genital tract 1994 Springer-Verlag New York 487 528
7. A.H. Ligon, and C.C. Morton Genetics of uterine leiomyomata Genes Chromosomes Cancer 28 2000 235 245
8. D. Linder, and S.M. Gartler Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas Science 150 1965 67 69
9. D.E. Townsend, R.S. Sparkes, M.C. Baluda, and G. McClelland Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis of glucose-6-phosphate dehydrogenase Am J Obstet Gynecol 107 1970 1168 1173
10. R.D. Mashal, M.L. Schoenberg Fejzo, A.J. Friedman, N. Mitchner, R.A. Nowak, M.S. Rein, C.C. Morton, and J. Sklar Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata Genes Chromosomes Cancer 11 1994 1 6
11. th annual meeting of the Society for Gynecologic Investigation; San Antonio, TX, 1992.
12. K. Hashimoto, C. Azuma, S. Kamiura, T. Kimura, T. Nobunaga, T. Kanai, M. Sawada, S. Noguchi, and F. Saji Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene Gynecol Obstet Invest 40 1995 204 208
13. M. Nilbert, and S. Heim Uterine leiomyoma cytogenetics Genes Chromosomes Cancer 2 1990 3 13
14. M. Nilbert, and B. Strömbeck Independent origin of uterine leiomyomas with karyotypically identical alterations Gynecol Obstet Invest 33 1992 246 248
15. Y.P. Xing, W.L. Powell, and C.C. Morton The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata Cancer Genet Cytogenet 98 1997 69 74
16. C.C. Morton Many tumors and many genes. Genetics of uterine leiomyomata Am J Pathol 153 1998 1015 1020
17. B.J. Quade, C.M. McLachlin, V. Soto-Wright, J. Zuckerman, G.L. Mutter, and C.C. Morton Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation Am J Pathol 150 1997 2153 2166
18. D.Y. Baschinsky, A. Isa, T.H. Niemann, T.W. Prior, J.G. Lucas, and W.L. Frankel Diffuse leiomyomatosis of the uterus. A case report with clonality analysis Hum Pathol 31 2000 1429 1432
19. Y.Y. Ozisik, A.M. Meloni, A.A. Sandberg, U. Surti, H. Tobon, and J. Davare Cytogenetic findings in a symplastic leiomyoma Cancer Genet Cytogenet 67 1993 79 80
20. A.A. Sandberg, and J.A. Bridge The cytogenetics of bone and soft tissue tumors 1994 RG Landes Co Austin
21. M. Kiechle-Schwarz, C. Sreekantaiah, C.S. Berger, S. Pedron, M.T. Medchill, U. Surti, and A.A. Sandberg Nonrandom cytogenetic changes in leiomyomas of the female genitourinary tract Cancer Genet Cytogenet 53 1991 125 136
22. M.S. Rein, A.J. Friedman, R.L. Barbieri, K. Pavelka, J.A. Fletcher, and C.C. Morton Cytogenetic abnormalities in uterine leiomyomata Obstet Gynecol 77 1991 923 926
23. A.M. Meloni, U. Surti, A.M. Contento, J. Davar, and A.A. Sandberg Uterine leiomyomas: cytogenetic and histologic profile Obstet Gynecol 80 1992 209 217
24. K. Mrózek, Z. Gibas, and J. Limon Specific chromosome aberrations in human soft-tissue tumors and their diagnostic significance Pol Tyg Lek 50 1995 85 89
25. N. Pandis, S. Heim, G. Bardi, U.-M. Flodérus, H. Willén, N. Mandahl, and F. Mitelman Chromosome analysis of 96 uterine leiomyomas Cancer Genet Cytogenet 55 1991 11 18
26. M.S. Rein, A.J. Friedman, R.L. Barbieri, K. Pavelka, J.A. Fletcher, and C.C. Morton Cytogenetic abnormalities in uterine leiomyomata Obstet Gynecol 77 1991 923 926
27. B.J. Quade Pathology, cytogenetics and molecular biology of uterine leiomyomas and their smooth muscle lesions Curr Opin Obstet Gynecol 7 1995 35 42
28. N. Pandis, S. Heim, H. Willén, G. Bardi, U.-M. Flodérus, N. Mandahl, and F. Mitelman Histologic-cytogenetic correlations in uterine leiomyomas Int J Gynecol Cancer 1 1991 163 168
29. I. Brosens, J. Deprest, P. Dal Cin, and H. Van den Berghe Clinical significance of cytogenetic abnormalities in uterine myomas Fertil Steril 69 1998 232 235
30. I. Brosens, E. Johannisson, P. Dal Cin, J. Deprest, and H. Van den Berghe Analysis of the karyotype and deoxyribonucleic acid content of uterine myomas in premenopausal, menopausal, and gonadotropin-releasing hormone agonist-treated females Fertil Steril 66 1996 376 379
31. M.S. Rein, W.L. Powell, F.C. Walters, S. Weremowicz, R.M. Cantor, R.L. Barbieri, and C.C. Morton Cytogenetic abnormalities in uterine myomas are associated with myoma size Mol Hum Reprod 4 1998 83 86
32. M. Nilbert, S. Heim, N. Mandahl, U.-M. Flodérus, H. Willén, M. Åkerman, and F. Mitelman Different karyotypic abnormalities, t(1;6) and del(7), in two uterine leiomyomas from the same patient Cancer Genet Cytogenet 42 1989 51 53
33. C. Sreekantaiah, and A.A. Sandberg Clustering of aberrations to specific chromosome regions in benign neoplasms Int J Cancer 48 1991 194 198
34. C. Turc-Carel, P. Dal Cin, L. Boghosian, J. Terk-Zakarian, and A.A. Sandberg Consistent breakpoints in region 14q22-q24 in uterine leiomyoma Cancer Genet Cytogenet 32 1988 25 31
35. S. Heim, M. Nilbert, R. Vanni, U.-M. Flodérus, N. Mandahl, S. Liedgren, U. Lecca, and F. Mitelman A specific translocation, t(12;14)(q14-15; q23-24), characterizes a subgroup of uterine leiomyomas Cancer Genet Cytogenet 32 1988 13 17
36. R. Vanni, M. Nieddu, R. Paoli, and U. Lecca Uterine leiomyoma cytogenetics. I. Rearrangements of chromosome 12 Cancer Genet Cytogenet 37 1989 49 54
37. S. Wanschura, P. Dal Cin, B. Kazmierczak, S. Bartnitzke, H. Van den Berghe, and J. Bullerdiek Hidden paracentric inversions of chromosome arm 12q affecting the HMGIC gene Genes Chromosomes Cancer 18 1997 322 323
38. J. Bullerdiek, and B. Rommel Diagnostic and molecular implications of specific chromosomal translocations in mesenchymal tumors Histol Histopathol 14 1999 1165 1173
39. C. Turc-Carel, P. Dal Cin, U. Rao, C. Karakousis, and A.A. Sandberg Cytogenetic studies of adipose tissue tumors. I. A benign lipoma with reciprocal translocation t(3;12)(q28;q14) Cancer Genet Cytogenet 23 1986 283 289
40. J. Bullerdiek, S. Bartnitzke, M. Weinberg, R. Chilla, J. Haubrich, and W. Schloot Rearrangements of chromosome region 12q13-15 in pleomorphic adenomas of the salivary gland (PSA) Cytogenet Cell Genet 45 1987 187 190
41. G. Calabrese, C. Di Virgilio, E. Cianchetti, P.G. Franchi, L. Stuppia, G. Parruti, P.G. Bianchi, and G. Palka Chromosome abnormalities in breast fibroadenomas Genes Chromosomes Cancer 3 1991 202 204
42. N. Mandahl, C. Örndal, S. Heim, H. Willén, A. Rydholm, H.C. Bauer, and F. Mitelman Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas Cancer 71 1993 3009 3013
43. R. Vanni, P. Dal Cin, S. Marras, P. Moerman, M. Andria, E. Valdes, J. Deprest, and H. Van den Berghe Endometrial polyp: Another benign tumor characterized by 12q13-15 changes Cancer Genet Cytogenet 68 1993 32 33
44. P. Dal Cin, R. Vanni, S. Marras, P. Moerman, P. Kool, M. Andria, E. Valdes, J. Deprest, W. Van de Ven, and H. Van den Berghe Four cytogenetic subgroups can be identified in endometrial polyps Cancer Res 55 1995 1565 1568
45. J.A. Fletcher, J. Longtine, K. Wallace, S.J. Mentzer, and D.J. Sugarbaker Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: Evidence for a pathogenetic relationship with lipomas and leiomyomas Genes Chromosomes Cancer 12 1995 220 223
46. B. Kazmierczak, S. Wanschura, K. Meyer-Bolte, J. Caselitz, P. Meister, S. Bartnitzke, W. Van de Ven, and J. Bullerdiek Cytogenetic and molecular analysis of an aggressive angiomyxoma Am J Pathol 147 1995 580 585
47. A.A. Sandberg Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Lipoma Cancer Genet Cytogenet 150 2004 93 115
48. Y.Y. Ozisik, A.M. Meloni, C.F. Stephenson, A. Peier, G.E. Moore, and A.A. Sandberg Chromosome abnormalities in breast fibroadenomas Cancer Genet Cytogenet 77 1994 125 128
49. M. Schoenberg Fejzo, S.-J. Yoon, K.T. Montgomery, M.S. Rein, S. Weremowicz, K.S. Krauter, T.E. Dorman, J.A. Fletcher, J. Mao, D.T. Moir, R.S. Kucherlapati, and C.C. Morton Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: Physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata Genomics 26 1995 265 271
50. E.F.P.M. Schoenmakers, J.M.W. Geurts, P.F.J. Kools, R. Mols, C. Huysmans, J. Bullerdiek, H. Van den Berghe, and W.J.M. Van de Ven A 6-mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors Genomics 29 1995 665 678
51. E.F.P.M. Schoenmakers, S. Wanschura, R. Mols, J. Bullerdiek, H. Van den Berghe, and W.J.M. Van de Ven Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours Nature Genet 10 1995 436 444
52. W.J.M. Van de Ven, E.F.P.M. Schoenmakers, S. Wanschura, B. Kazmierczak, P.F.J. Kools, J.M.W. Geurts, S. Bartnitzke, H. Van den Berghe, and J. Bullerdiek Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors Genes Chromosomes Cancer 12 1995 296 303
53. S. Wanschura, Y. Hennig, U. Deichert, E.F.P.M. Schoenmakers, W.J.M. Van de Ven, S. Bartnitzke, and J. Bullerdiek Molecular-cytogenetic refinement of the 12q14→q15 breakpoint region affected in uterine leiomyomas Cytogenet Cell Genet 71 1995 131 135
54. S. Wanschura, B. Kazmierczak, E. Schoenmakers, E. Meyen, S. Bartnitzke, W. Van de Ven, J. Bullerdiek, and W. Schloot Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15 Genes Chromosomes Cancer 14 1995 68 70
55. S. Weremowicz, and C.C. Morton Is HMGIC rearranged due to cryptic paracentric inversion of 12q in karyotypically normal uterine leiomyomas? Genes Chromosomes Cancer 24 1999 172 173
56. B.J. Quade, S. Weremowicz, D.M. Neskey, R. Vanni, C. Ladd, P. Dal Cin, and C.C. Morton Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15 Cancer Res 63 2003 1351 1358
57. Y.Y. Ozisik, A.M. Meloni, M. Powell, U. Surti, and A.A. Sandberg Chromosome 7 biclonality in uterine leiomyoma Cancer Genet Cytogenet 67 1993 59 64
58. Y.Y. Ozisik, A.M. Meloni, U. Surti, and A.A. Sandberg Deletion 7q22 in uterine leiomyoma. A cytogenetic review Cancer Genet Cytogenet 71 1993 1 6
59. M.S. Sargent, S. Weremowicz, M.S. Rein, and C.C. Morton Translocations in 7q22 define a critical region in uterine leiomyomata Cancer Genet Cytogenet 77 1994 65 68
60. C.S. Ishwad, R.E. Ferrell, J. Davare, A.M. Meloni, A.A. Sandberg, and U. Surti Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas Genes Chromosomes Cancer 15 1995 51 55
61. C.S. Ishwad, R.E. Ferrell, K. Hanley, J. Davare, A.M. Meloni, A.A. Sandberg, and U. Surti Two discrete regions of deletion at 7q in uterine leiomyomas Genes Chromosomes Cancer 19 1997 156 160
62. L. Boghosian, P. Dal Cin, and A.A. Sandberg An interstitial deletion of chromosome 7 may characterize a subgroup of uterine leiomyomas Cancer Genet Cytogenet 34 1988 207 208
63. S.N. Sait, P. Dal Cin, S. Ovanessoff, and A.A. Sandberg A uterine leiomyoma showing both t(12;14) and del(7) abnormalities Cancer Genet Cytogenet 37 1989 157 161
64. Y. Hennig, U. Deichert, U. Bonk, B. Thode, S. Bartnitzke, and J. Bullerdiek Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells Mol Hum Reprod 5 1999 1150 1154
65. P. Dal Cin, S. Wanschura, M.R. Christiaens, I. Van den Berghe, P. Moerman, P. Polito, B. Kazmierczak, J. Bullerdiek, and H. Van den Berghe Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGI(Y) Cancer 20 1997 90 92
66. G. Tallini, P. Dal Cin, K.J. Rhoden, G. Chiapetta, G. Manfioletti, V. Giancotti, A. Fusco, H. Van den Berghe, and R. Sciot Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors. Immunohistochemical reactivity correlates with karyotypic alterations Am J Pathol 151 1997 37 43
67. A.J. Williams, W.L. Powell, T. Collins, and C.C. Morton HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm Am J Pathol 150 1997 911 918
68. S. Xiao, M. Lux, R. Reeves, T. Hudson, and J. Fletcher HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma Am J Pathol 150 1997 901 910
69. K.S. Sornberger, S. Weremowicz, A.J. Williams, B.J. Quade, A.H. Ligon, F. Pedeutour, R. Vanni, and C.C. Morton Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6 Cancer Genet Cytogenet 114 1999 9 16
70. Y.Y. Ozisik, A.M. Meloni, O. Altungoz, U. Surti, and A.A. Sandberg Translocation (6;10)(p21;q22) in uterine leiomyomas Cancer Genet Cytogenet 79 1995 136 138
71. Y. Hennig, U. Deichert, C. Stern, A. Ghassemi, B. Thode, U. Bonk, P. Meister, S. Bartnitzke, and J. Bullerdiek Structural aberrations of chromosome 6 in three uterine smooth muscle tumors Cancer Genet Cytogenet 87 1996 148 151
72. S.-X. Fan, C. Sreekantaiah, C.S. Berger, M. Medchill, S. Pedron, and A.A. Sandberg Cytogenetic findings in nine leiomyomas of the uterus Cancer Genet Cytogenet 47 1990 179 189
73. J. Mark, G. Havel, C. Grepp, R. Dahlenfors, and B. Wedell Chromosomal patterns in human benign uterine leiomyomas Cancer Genet Cytogenet 44 1990 1 13
74. Y.Y. Ozisik, A.M. Meloni, U. Surti, J. Davare, and A.A. Sandberg Inversion (X)(p22q13) in a uterine leiomyoma Cancer Genet Cytogenet 61 1992 131 133
75. M. Nilbert, S. Heim, N. Mandahl, U.-M. Flodérus, H. Willén, M. Åkerman, and F. Mitelman Ring formation and structural rearrangements of chromosome 1 as secondary changes in uterine leiomyomas with t(12;14)(q14-15;q23-24) Cancer Genet Cytogenet 36 1988 183 190
76. C. Casartelli, M.A.M. Ruzzene, S.R. Rogatto, and P.M.P. Philbert A cytogenetic study of uterine leiomyomas Cancer Genet Cytogenet 41 1989 279
77. R. Vanni, U. Lecca, and G. Faa Uterine leiomyoma cytogenetics. II. Report of forty cases Cancer Genet Cytogenet 53 1991 247 256
78. R. Vanni, P. Dal Cin, and H. Van den Berghe Is the chromosome band 1p36 another hotspot for rearrangements in uterine leiomyoma? Genes Chromosomes Cancer 2 1990 255 256
79. G. Havel, B. Wedell, R. Dahlenfors, and J. Mark Cytogenetic relationship between uterine lipoleiomyomas and typical leiomyomas Virchows Archiv B Cell Pathol 57 1989 77 79
80. J. Mark, G. Havel, C. Grepp, R. Dahlenfors, and B. Wedell Cytogenetical observations in human benign uterine myomas Anticancer Res 8 1988 621 626
81. Y.Y. Ozisik, A.M. Meloni, U. Surti, and A.A. Sandberg Involvement of 10q22 in leiomyoma Cancer Genet Cytogenet 69 1993 132 135
82. Y.Y. Ozisik, A.M. Meloni, J.F. Stone, A.A. Sandberg, and U. Surti Spontaneous expression of the chromosome fragile site at 10q23 in leiomyoma Cancer Genet Cytogenet 74 1994 73 75
83. M. Nilbert, S. Heim, N. Mandahl, U.-M. Flodérus, H. Willén, M. Åkerman, and F. Mitelman Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas Hum Genet 85 1990 605 611
84. P. Dal Cin, P. Moerman, J. Deprest, I. Brosens, and H. Van den Berghe A new cytogenetic subgroup is uterine leiomyoma is characterized by a deletion of the long arm of chromosome 3 Genes Chromosomes Cancer 13 1995 219 220
85. A.M. Meloni, U. Surti, and A.A. Sandberg Deletion of chromosome 13 in leiomyomas of the uterus Cancer Genet Cytogenet 53 1991 199 203
86. J. Mark, G. Havel, R. Dahlenfors, and B. Wedell Cytogenetic of multiple uterine leiomyomas, parametrial leiomyoma and disseminated peritoneal leiomyomatosis Anticancer Res 11 1991 33 40
87. R. Vanni, N. Van Roy, U. Lecca, and F. Speleman Uterine leiomyoma cytogenetics. III. Interphase cytogenetic analysis of karyotypically normal uterine leiomyoma excludes possibility of undetected trisomy 12 Cancer Genet Cytogenet 62 1992 40 42
88. S. Hayashi, N. Miharu, E. Okamoto, O. Samura, T. Hara, and K. Ohama Detection of chromosomal abnormalities in uterine leiomyoma using conventional cytogenetic method and interphase fluorescence in situ hybridization Cancer Genet Cytogenet 89 1996 98 104
89. S. Hayashi, N. Miharu, E. Okamoto, O. Samura, T. Hara, and K. Ohama Detection of chromosomal abnormalities of chromosome 12 in uterine leiomyoma using fluorescence in situ hybridization Jpn J Human Genet 41 1996 193 202
90. E.F.P.M. Schoenmakers, P.F.J. Kools, R. Mols, B. Kazmierczak, S. Bartnitzke, J. Bullerdiek, P. Dal Cin, P.J. De Jong, H. Van den Berghe, and W.J.M. Van de Ven Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma Genomics 20 1994 210 222
91. W.J.M. Van de Ven Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes Eur J Obstet Gynecol Reprod Biol 81 1998 289 293
92. B. Kazmierczak, S. Bol, S. Wanschura, S. Bartnitzke, and J. Bullerdiek PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line Genes Chromosomes Cancer 17 1996 191 193
93. R. Vanni, S. Marras, E.F.P.M. Schoenmakers, P. Dal Cin, B. Kazmierczak, G. Senger, J. Bullerdiek, W.J.M. Van de Ven, and H. Van den Berghe Molecular cytogenetic characterization of del(7q) in two uterine leiomyoma-derived cell lines Genes Chromosomes Cancer 18 1997 155 161
94. R. Vanni, E.F.P.M. Schoenmakers, and M. Andria Deletion 7q in uterine leiomyoma: Fluorescence in situ hybridization characterization on primary cytogenetic preparations Cancer Genet Cytogenet 113 1999 183 187
95. Y. Hennig, P. Rogalla, S. Wanschura, G. Frey, U. Deichert, S. Bartnitzke, and J. Bullerdiek HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality Cancer Genet Cytogenet 96 1997 129 133
96. B. Bhugra, T.A. Smolarek, R.A. Lynch, A.M. Meloni, A.A. Sandberg, L. Deaven, and A.G. Menon Cloning of a breakpoint cluster region on chromosome 14 in uterine leiomyoma Cancer Lett 126 1998 119 126
97. A.H. Ligon, I.C. Scott, K. Takahara, D.S. Greenspan, and C.C. Morton PCOLCE deletion and expression analyses in uterine leiomyomata Cancer Genet Cytogenet 137 2002 133 137
98. F. Pedeutour, B.J. Quade, S. Weremowicz, P. Dal Cin, S. Ali, and C.C. Morton Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata Genes Chromosomes Cancer 23 1998 361 366
99. F. Pedeutour, B.J. Quade, K. Sornberger, G. Tallini, A.H. Ligon, S. Weremowicz, and C.C. Morton Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12 and 14 Genes Chromosomes Cancer 27 2000 209 215
100. P. Rogalla, C. Blank, R. Helbig, W. Wosniok, and J. Bullerdiek Significant correlation between the breakpoints of rare clonal aberrations in benign solid tumors and the assignment of HMGIY retropseudogenes Cancer Genet Cytogenet 130 2001 51 56
101. K. Han, W. Lee, C.P. Harris, R.C. Simsiman, K. Lee, C. Kang, and L.F. Meisner Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissue Cancer Genet Cytogenet 74 1994 19 24
102. L. Tietze, K. Günther, A. Hörbe, C. Pawlik, B. Klosterhalfen, S. Handt, and S. Merkelbach-Bruse Benign metastasizing leiomyoma: A cytogenetically balanced but clonal disease Hum Pathol 31 2000 126 128
103. J.P. Packenham, S. du Manoir, E. Schröck, J.I. Risinger, D. Dixon, D.N. Denz, J.A. Craig Evans, A. Berchuck, J.C. Barrett, T.R. Devereux, and T. Ried Analysis of genetic alterations in leiomyomas and leiomyosarcomas by comparative genomic hybridization Mol Carcinogen 19 1997 273 279
104. B. Levy, T. Mukherjee, and K. Hirschhorn Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization Cancer Genet Cytogenet 121 2000 1 8
105. J.L. Hess Chromosomal translocations in benign tumors. The HMGI proteins Am J Clin Pathol 109 1998 251 261
106. Y. Hennig, S. Wanschura, U. Deichert, S. Bartnitzke, and J. Bullerdiek Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps Mol Hum Reprod 2 1996 277 283
107. M. Klotzbücher, A. Wasserfall, and U. Fuhrmann Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas Am J Pathol 155 1999 1535 1542
108. J.L. Hess, and P. Kossev Molecular genetics of benign tumors Cancer Invest 20 2002 362 372
109. P. Rogalla, K. Drechsler, G. Frey, Y. Hennig, B. Helmke, U. Bonk, and J. Bullerdiek HMGI-C expression patterns in human tissues: implications for the genesis of frequent mesenchymal tumors Am J Pathol 149 1996 775 779
110. G. Tallini, and P. Dal Cin HMGI(Y) and HMGI-C dysregulation: A common occurrence in human tumors Adv Anat Pathol 6 1999 237 246
111. R. Reeves Molecular biology of HMGA proteins: hubs of nuclear function Gene 277 2001 63 81
112. D.S. Hunter, M. Klotzbücher, H. Kugoh, S.-L. Cai, J.P. Mullen, G. Manfioletti, U. Fuhrman, and C.L. Walker Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function Cancer Res 62 2002 3766 3772
113. G.J.F. Gattas, B.J. Quade, R.A. Nowak, and C.C. Morton HMGIC expression in human adult and fetal tissues and in uterine leiomyomata Genes Chromosomes Cancer 25 1999 316 322
114. G. Chiappetta, G. Manfioletti, F. Pentimalli, N. Abe, M. Di Bonito, M.T. Vento, A. Giuliano, M. Fedele, G. Viglietto, M. Santoro, T. Watanabe, V. Giancotti, and A. Fusco High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases Int J Cancer 91 2001 147 151
115. S. Wanschura, B. Kazmierczak, S. Bartnitzke, J. Bullerdiek, W. Schloot, E. Schoenmakers, E. Meyen, and W. Van de Ven Molecular cytogenetic assignment of the chromosome 12 breakpoints in many benign tumors to 12q15 affecting the HMGIC gene Genes Chromosomes Cancer 15 1996 195 196
116. H.R. Ashar, M. Schoenberg Fejzo, A. Tkachenko, X. Zhou, J.A. Fletcher, S. Weremowicz, C.C. Morton, and K. Chada Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains Cell 82 1995 57 65
117. S.-Y. Dong, R. Morgan, J. Stone, A.M. Meloni-Ehrig, Z. Chen, M.M. Malawer, and A.A. Sandberg Translocation (12;14) in lipoma: a case report and review of the literature Cancer Genet Cytogenet 103 1998 59 61
118. T. Takahashi, N. Nagai, H. Oda, K. Ohama, N. Kamada, and K. Miyagawa Evidence for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma Genes Chromosomes Cancer 30 2001 196 201
119. H.R. Ashar, L. Cherath, K.M. Przybysz, and K. Chada Genomic characterization of human HMGI-C, a member of the accessory transcription factor family found at translocation breakpoints in lipomas Genomics 31 1996 207 214
120. M. Bustin, and R. Reeves High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function Prog Nucleic Acid Res 54 1996 35 100
121. E.F.P.M. Schoenmakers, and W.J.M. Van de Ven From chromosome aberrations to the high mobility group protein gene family: Evidence for common genetic denominator in benign solid tumor development Cancer Genet Cytogenet 95 1997 51 58
122. M. Friedmann, L.T. Holth, H.Y. Zoghbi, and R. Reeves Organization, inducible expression and chromosome localization of the human HMGI(Y) nonhistone protein gene Nucl Acids Res 21 1993 4259 4267
123. V. Giancotti, M.T. Berlingieri, P.P. Di Fiore, A. Fusco, G. Vecchio, and C. Crane-Robinson Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus Cancer Res 45 1985 6051 6057
124. V. Giancotti, B. Pani, P. D'Andrea, M.T. Berlingieri, P.P. Di Fiore, A. Fusco, G. Vecchio, R. Philip, C. Crane-Robinson, and R.H. Nicolas Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c-myc and polyoma middle T genes EMBO J 6 1987 1981 1987
125. V. Giancotti, E. Buratti, L. Perissin, S. Zorzet, A. Balmain, G. Portella, A. Fusco, and G.H. Goodwin Analysis of the HMGI nuclear proteins in mouse neoplastic cells inducted by different procedures Exp Cell Res 184 1989 538 545
126. M.T. Berlingen, G. Manfioletti, and M. Santoro Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells Mol Cell Biol 15 1995 1545 1553
127. M. Schoenberg Fejzo, H.R. Ashar, K.S. Krauter, W.L. Powell, M.S. Rein, S. Weremowicz, S.-J. Yoon, R.S. Kucherlapati, K. Chada, and C.C. Morton Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas Genes Chromosomes Cancer 17 1996 1 6
128. K. Kurose, N. Mine, A. Iida, H. Nagai, H. Harada, T. Araki, and M. Emi Three aberrant splicing variants of the HMGIC gene transcribed in uterine leiomyomas Genes Chromosomes Cancer 30 2001 212 217
129. K.L. Gross, and C.C. Morton Genetics and the development of fibroids Clin Obstet Gynecol 44 2001 335 349
130. M. Shozu, K. Murakami, T. Segawa, T. Kasai, H. Ishikawa, K. Shinohara, M. Okada, and M. Inoue Decreased expression of early growth response-1 and its role in uterine leiomyoma growth Cancer Res 64 2004 4677 4684
131. N. Mine, K. Kurose, H. Nagai, D. Doi, Y. Ota, K. Yoneyama, H. Konishi, T. Araki, and M. Emi Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas J Hum Genet 46 2001 408 412
132. M. Hisaoka, W.-Q. Sheng, A. Tanaka, and H. Hashimoto HMGIC alterations in smooth muscle tumors of soft tissues and other sites Cancer Genet Cytogenet 138 2002 50 55
133. K.L. Gross, D.M. Neskey, N. Manchanda, S. Weremowicz, M.S. Kleinman, R.A. Nowak, A.H. Ligon, P. Rogalla, K. Drechsler, J. Bullerdiek, and C.C. Morton HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies Genes Chromosomes Cancer 38 2003 68 79
134. K. Hug, M.K. Doney, M.J. Tyler, D.A. Grundy, S. Soukup, T.W. Houseal, and A.G. Menon Physical mapping of the uterine leiomyoma t(12;14)(q13-15;q24.1) breakpoint on chromosome 14 between SPTB and D14S77 Genes Chromosomes Cancer 11 1994 263 266
135. M.K. Doney, S.C. Gerken, R. Lynch, B. Bhugra, K. Hug, R. White, J. Weissenbach, and A.G. Menon Precise mapping of t(12;14) leiomyoma breakpoint on chromosome 14 between D14S298 and D14S540 Cancer Lett 96 1995 245 252
136. S. Mosselman, J. Polman, and R. Dijkema ER Beta: identification and characterization of a novel human estrogen receptor FEBS Lett 392 1996 49 53
137. E. Enmark, M. Pelto-Huikko, K. Grandien, S. Lagercrantz, J. Lagercrantz, G. Fried, M. Nordenskjold, and J.-A. Gustafsson Human estrogen receptor B-gene structure, chromosomal localization, and expression pattern J Clin Endocrinol Metab 82 1997 4258 4265
138. E.F.P.M. Schoenmakers, C. Huysmans, and W.J.M. Van de Ven Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas Cancer Res 59 1999 19 23
139. S.E. Ingraham, R.A. Lynch, S. Kathiresan, A.J. Buckler, and A.G. Menon hREC2, a RAD51-like gene, is disrupted by t(12;14) in a uterine leiomyoma Cancer Genet Cytogenet 115 1999 56 61
140. Z. Shu, S. Smith, L. Wang, M.C. Rice, and E.B. Kmiec Disruption of muREC2/RAD51L1 in mice results in early embryonic lethality which can be partially rescued in a p53+ background Mol Cell Biol 19 1999 8686 8693
141. D. Schild, Y.C. Lio, D.W. Collins, T. Tsomondo, and D.J. Chen Evidence for simultaneous protein interactions between human RAD51 paralogs J Biol Chem 275 2000 16443 16449
142. R.A. Lynch, M. Piper, A. Bankier, B. Bhugra, U. Surti, J. Liu, A. Buckler, P.H. Dear, and A.G. Menon Genomic and functional map of the chromosome 14 t(12;14) breakpoint cluster region in uterine leiomyoma Genomics 52 1998 17 26
143. S. Hauke, V. Rippe, and J. Bullerdiek Chromosomal rearrangements leading to abnormal splicing within intron 4 of HJMGIC? Genes Chromosomes Cancer 30 2001 302 304
144. S. Hauke, A.M. Flohr, P. Rogalla, and J. Bullerdiek Sequencing of intron 3 of HMGA2 uncovers the existence of a novel exon Genes Chromosomes Cancer 34 2002 17 23
145. K. Kurose, N. Mine, D. Doi, Y. Ota, K. Yoneyama, H. Konishi, T. Araki, and M. Emi Novel gene fusion of COX6C at 8q22-23 to HMGIC at 12q15 in uterine leiomyoma Genes Chromosomes Cancer 27 2000 303 307
146. B. Kazmierczak, Y. Hennig, S. Wanschura, P. Rogalla, S. Bartnitzke, W. Van de Ven, and J. Bullerdiek Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene Cancer Res 55 1995 6038 6039
147. N. Mine, K. Kurose, H. Konishi, T. Araki, H. Nagai, and M. Emi Fusion of a sequence from HE110 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma Jpn J Cancer Res 92 2001 135 139
148. B. Kazmierczak, Y. Pohnke, and J. Bullerdiek Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations Genomics 38 1996 223 226
149. M. Fedele, S. Battista, G. Manfioletti, C.M. Croce, V. Giancotti, and A. Fusco Role of the high mobility group A proteins in human lipomas Carcinogenesis 22 2001 1583 1591
150. G.M. Pierantoni, S. Battista, F. Pentimallli, M. Fedele, R. Visone, A. Federico, M. Santoro, G. Viglietto, and A. Fusco A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas Carcinogenesis 24 2003 1861
151. B. Kazmierczak, P. Dal Cin, S. Wanschura, L. Borrmann, A. Fusco, H. Van den Berghe, and J. Bullerdiek HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors Genes Chromosomes Cancer 23 1998 279 285
152. D. Thanos, and T. Maniatis The high mobility group protein HMGI(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene Cell 71 1992 777 789
153. S. Chuvpilo, C. Schomberg, R. Gerwig, A. Heinfling, R. Reeves, F. Grummt, and E. Surfling Multiple closely-linked NFAT/octamer and HMGI(Y) binding sites are part of the interleukin-4 promoter Nucleic Acids Res 21 1993 5694 5704
154. W. Du, D. Thanos, and T. Maniatis Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements Cell 74 1993 887 898
155. M.Z. Whitley, D. Thanos, M.A. Read, T. Maniatis, and T. Collins A striking similarity in the organization of the E-selectin and β interferon gene promoters Mol Cell Biol 14 1994 6464 6475
156. S.A. Abdulkadir, S. Krishna, D. Thanos, T. Maniatis, J.L. Strominger, and S.J. Ono Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression J Exp Med 182 1995 487 500
157. S. John, R.B. Reeves, J.X. Lin, R. Child, J.M. Leiden, C.B. Thompson, and W.J. Leonard Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins Mol Cell Biol 15 1995 1786 1796
158. J. Kim, R. Reeves, P. Rothman, and M. Boothby The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germline ε RNA promoter Eur J Immunol 25 1995 798 808
159. L.D. Wood, A.A. Farmer, and A. Richmond HMGI(Y) and SP1 in addition to NF-κB regulate transcription of the MRSA/GROα gene Nucleic Acids Res 23 1995 4210 4219
160. R. Gokdeniz, B. Mizrak, S. Ozen, and N. Bazoglu Endothelial nitric oxide synthase expression in leiomyoma and parental myometrium Gynecol Obstet Invest 49 2000 132 136
161. T.G. Ram, R. Reeves, and H.L. Hosick Elevated HMGI(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells Cancer Res 53 1993 2655 2660
162. Y. Tamini, H.G. van der Poel, M.M. Denyn, R. Umbas, H.F. Karthaus, F.M.
163. G. Chiappetta, A. Bandiera, M.T. Berlingiera, R. Visconti, G. Manfioletti, S. Battista, F.J. Martinez-Tello, M. Santoro, V. Giancotti, and A. Fusco The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasia Oncogene 10 1995 1307 1314
164. G. Chiappetta, G. Tallini, M.C. De Biasio, G. Manfioletti, F.J. Martinez-Tello, F. de Nigris, A. Mastro, G. Botti, M. Fedele, N. Berger, M. Santoro, V. Giancotti, and A. Fusco Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma Cancer Res 58 1998 4193 4198
165. N. Abe, T. Watanabe, M. Sugiyama, H. Uchimura, G. Chiappetta, A. Fuso, and Y. Atomi Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker Cancer Res 59 1999 1169 1174
166. J. Kim, R. Reeves, P. Rothman, and M. Boothby The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germline ε RNA promoter Eur J Immunol 25 1995 798 808
167. G. Chiappetta, V. Avantaggiato, R. Visconti, M. Fedele, S. Battista, F. Trapasso, B.M. Merciai, V. Fidanza, V. Giancotti, M. Santoro, A. Simeone, and A. Fusco High level expression of the HMGI(Y) gene during embryonic development Oncogene 13 1996 2439 2446
168. C. Blank, P. Rogalla, K.H. Tran, and J. Bullerdiek A novel high mobility group protein gene is a candidate for Xp22 abnormalities in uterine leiomyomas and other benign tumors Cancer Genet Cytogenet 121 2000 172 180
169. P. Polito, P. Dal Cin, B. Kazmierczak, P. Rogalla, J. Bullerdiek, and H. Van den Berghe Deletion of HMG17 in uterine leiomyomas with ring chromosome 1 Cancer Genet Cytogenet 108 1999 107 109
170. N. Pandis, S. Heim, G. Bardi, U.-M. Flodérus, H. Willén, N. Mandahl, and F. Mitelman Parallel karyotypic evolution and tumor progression in uterine leiomyoma Genes Chromosomes Cancer 2 1990 311 317
171. S.M. Sell, C. Tullis, D. Stracner, C.-Y. Song, and J. Gewin Minimal interval defined on 7q in uterine leiomyoma Cancer Genet Cytogenet 157 2005 67 69
172. S.M. Sell, O. Altungoz, A.A. Prowse, A.M. Meloni, U. Surti, and A.A. Sandberg Molecular analysis of chromosome 7q21.3 in uterine leiomyoma: Analysis using markers with linkage to insulin resistance Cancer Genet Cytogenet 100 1998 165 168
173. X. Mao, R. Barfoot, R.A. Hamoudi, D.F. Easton, A.M. Flanagan, and M.R. Stratton Allelotype of uterine leiomyomas Cancer Genet Cytogenet 114 1999 89 95
174. G. Vachon, B. Cohen, C. Pfeifle, M.E. McGuffin, J. Botas, and S.M. Cohen Homeotic genes of the bithorax complex repress limb development in the abdomen of the Drosophila embryo through the target gene Distalless Cell 71 1992 437 450
175. L.-C. Tsui, H. Donis-Keller, and K.-H. Grzeschik Report of the second international workshop on human chromosome 7 mapping, 1994 Cytogenet Cell Genet 71 1995 1 13
176. L.R. Osborne, J.A. Herbrick, T. Greavette, H.H. Heng, L.C. Tsui, and S.W. Scherer PMS2-related genes flank rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7 Genomics 45 1997 402 406
177. J. Yi, and M.C. Beckerle The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis Genomics 49 1998 314 316
178. O. van der Heijden, H.-C. Chiu, T.-C. Park, H. Takahashi, V.A. LiVolsi, J.I. Risinger, J.C. Barrett, A. Berchuck, A.C. Evans, K. Behbakht, A.W. Menzin, P.C. Liu, I. Benjamin, M.A. Morgan, S.A. King, S.C. Rubin, and J. Boyd Allelotype analysis of uterine leiomyoma: Localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q Mol Carcinog 23 1998 243 247
179. M. Ishiai, F.B. Dean, K. Okumura, M. Abe, K.-Y. Moon, A.A. Amin, K. Kagotani, H. Taguchi, Y. Murakami, F. Hanaoka, M. O'Donnell, J. Hurwitz, and T. Eki Isolation of human and fission yeast homologues of the budding yeast origin recognition complex subunit ORC5: Human homologue (ORC5L) maps to 7q22 Genomics 46 1997 294 298
180. D.G. Quintana, K.C. Thome, Z. Hou, A.H. Ligon, C.C. Morton, and A. Dutta ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases J Biol Chem 273 1998 27137 27145
181. A. Sourla, C. Polychronakos, W.R. Zeng, A. Nepveu, A. Kukuvitis, F. Naud, and M. Koutsilieris Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas Cancer Res 56 1996 3123 3128
182. W.R. Zeng, S.W. Scherer, M. Koutsilieris, J.J. Huizenga, F. Filteau, L.-C. Tsui, and A. Nepveu Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas Oncogene 14 1997 2355 2365
183. N.S. Moon, W.R. Zeng, P. Premdas, M. Santaguida, G. Bérubé, and A. Nepveu Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas In J Cancer 100 2002 429 432
184. H.R. Mason, R.A. Nowak, C.C. Morton, and J.J. Castellot Jr. Heparin inhibits the motility and proliferation of human myometrial and leiomyoma smooth muscle cells Am J Pathol 162 2003 1895 1904
185. G. Glockner, S. Scherer, R. Schattevoy, A. Boright, J. Weber, L.C. Tsui, and A. Rosenthal Large-scale sequencing of two regions in human chromosome 7q22: analysis of 650 kb of genomic sequence around the EOP and CUTL1 loci reveals 17 genes Genome Res 8 1998 1060 1073
186. A.H. John, and R. Martin Growth of leiomyomas with estrogen-progesterone therapy J Reprod Med 6 1997 56 59
187. J. Andersen, and R.L. Barbieri Abnormal gene expression in uterine leiomyomas J Soc Gynecol Invest 2 1995 633 672
188. A. Tiltman The effect of progestins on the mitotic activity of uterine fibromyomas Int J Gynecol Path 4 1985 89 96
189. K. Kawaguchi, S. Fujii, I. Konishi, T. Iwai, Y. Nanbu, H. Nonogaki, Y. Ishikawa, and T. Mori Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy Virchows Arch A Pathol Anat Histopathol 419 1991 309 315
190. D.D. Brandon, C.L. Bethea, E.Y. Strawn, M.J. Novy, K.A. Burry, M.S. Harrington, T.E. Erickson, C. Warner, E.J. Keenan, and G.M. Clinton Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas Am J Obstet Gynecol 169 1993 78 85
191. J.W.M. Höppener, S. Mosselman, P.J.M. Roholl, C. Lambrechts, R.J. Slebos, P. de Pagter-Holthuizen, C.J. Lips, H.S. Jansz, and J.S. Sussenbach Expression of insulin-like growth factor I and -II genes in human smooth muscle tumors EMBO J 7 1988 1379 1385
192. K.D. Boehm, M. Daimon, I.F. Gorodeski, L.A. Sheean, W.H. Utian, and J. Ilan Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues Mol Reprod Dev 27 1990 93 101
193. M.S. Rein, A.J. Friedman, M.R. Pandian, and L.J. Heffner The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist Obstet Gynecol 76 1990 388 394
194. Y. Chandrasekhar, J. Heiner, C. Osuampke, and M. Nagamani Insulin-like growth factors? I and II binding in human myometrium and leiomyomas Am J Obstet Gynecol 166 1992 64 69
195. L.C. Giudice, J.C. Irwin, B.A. Dsupin, E.M. Pannier, I.H. Jin, T.H. Vu, and A.R. Hoffman Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata Hum Reprod 8 1993 1796 1806
196. B.J. Vollenhoven, A.C. Herington, and D.L. Healy Messenger RNA encoding the insulin-like growth factors and their binding proteins, in women with fibroids, pretreated with luteinizing hormone-releasing hormone agonists Hum Reprod 9 1994 214 219
197. M.L. Harrison-Woolrych, D.S. Charnock-Jones, and S.K. Smith Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction J Clin Endocrinol Metab 78 1994 1179 1184
198. G.E. Hofmann, C.V. Rao, G.H. Barrows, G.S. Schultz, and J.S. Sanfilippo Binding sites for epidermal growth factor in human uterine tissues and leiomyomas J Clin Endocrinol Metab 58 1984 880 884
199. J. Yeh, M. Rein, and R. Nowak Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata Fertil Steril 56 1991 997 1000
200. E.C. Weir, D.I. Goad, A.G. Daifotis, W.J. Burtis, B.E. Dreyer, and R.A. Nowak Relative overexpression of the parathyroid hormone-related peptide gene in human leiomyomas Clin Endocrinol Metab 78 1994 784 789
201. M. Fujita Histological and biochemical studies of collagen in human uterine leiomyomas Hokkaido Igaku Zasshi 60 1985 602 615
202. A. Stewart, A.J. Friedman, K. Peck, and R.A. Nowak Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle J Clin Endocrinol Metab 79 1994 900 906
203. J. Andersen, E. Grine, C.L.Y. Eng, K. Zhao, R.L. Barbieri, J.C. Chumas, and P.R. Brink Expression of connexin-43 in human myometrium and leiomyoma Am J Obstet Gynecol 169 1993 1266 1276
204. S. Bongers-Binder, A. Burgardt, H. Seeger, W. Voelter, and T.H. Lippert Distribution of immunoreactive relaxin in the genital tract and in the mammary gland of non-pregnant women Clin Exp Obstet Gynecol XVIII 1991 161 164
205. B.P. Eyden, R.J. Hale, I. Richmond, and C.H. Buckley Cytoskeletal filaments in the smooth muscle cells of uterine leiomyomata and myometrium: An ultrastructural and immunohistochemical analysis Virchows Arch 420 1992 51 58
206. S.D. Erulkar, J. Ludmir, B. Ger, and R.D. Nori Expression of different potassium channels in cells isolated from human myometrium and leiomyomas Am J Obstet Gynecol 168 1993 1628 1639
207. F. Pekonen, T. Nyman, and E.-M. Rutanen Differential expression of mRNAs for endothelin-related proteins in human endometrium, myometrium and thyroid Mol Cell Endocrinol 103 1994 165 170
208. J.C.M. Tsibris, K.B. Porter, A. Jazayeri, G. Tzimas, H. Nau, H. Huang, K. Kuparadze, G.W. Porter, W.F. O'Brien, and W.N. Spellacy Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor γ, retinoid X receptor α, and all-trans retinoic acid than myometrium Cancer Res 59 1999 5737 5744
209. J. Andersen, V.M. DyReyes, R.L. Barbieri, D.M. Coachman, and R.J. Miksicek Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures J Soc Gynecol Invest 2 1995 542 551
210. A. Di Lieto, G. De Rosa, M. De Falco, F. Iannotti, S. Staibano, F. Pollio, M. Scaramellino, and G. Salvatore Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment Hum Pathol 33 2002 220 224
211. A. Salmi, and F.M. Rutanen C-fos and c-jun expression in human endometrium and myometrium Mol Cell Endocrinol 117 1996 233 240
212. M. Lessl, M. Klotzbuecher, S. Schoen, A. Reles, K. Stöckemann, and U. Fuhrmann Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium J Clin Endocrinol Metab 82 1997 2596 2600
213. X.-M. Tang, Q. Dou, Y. Zhao, F. McLean, J. Davis, and N. Chegini The expression of transforming growth factor-βs and TGF-β receptor mRNA and protein and the effect of TGF-βs on human myometrial smooth muscle cells in vitro Mol Hum Reprod 3 1997 233 240
214. N. Chegini, X.-M. Tang, and C. Ma Regulation of transforming growth factor-β1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells J Clin Endocrinol Metab 84 1996 4138 4143
215. B.-S. Lee, and R.A. Nowak Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-β3 (TGFβ3) and altered responses to the antiproliferative effects of TGFβ J Clin Endocrinol Metab 86 2001 913 920
216. M. Shozu, H. Sumitani, T. Segawa, H.-J. Yang, K. Murakami, T. Kasai, and M. Inoue Overexpression of aromatase P-450 in leiomyoma tissue is driven through the promoter I.4 of the aromatase P450 gene J Clin Endocrinol Metab 87 2002 2540 2548
217. N. Chegini, H. Rong, Q. Dou, S. Kipersztok, and R.S. Williams Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro J Clin Endocrinol Metab 81 1996 3215 3221
218. J.J. Tremblay, and J. Drouin Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Pix1 and SF-1 to enhance luteinizing hormone beta gene transcription Mol Cell Biol 19 1999 2567 2576
219. K.M. Skubitz, and A.P.N. Skubitz Differential gene expression in leiomyosarcoma Cancer 98 2003 1029 1038
220. K.M. Skubitz, and A.P.N. Skubitz Differential gene expression in uterine leiomyoma J Lab Clin Med 141 2003 297 308
221. J.C.M. Tsibris, J. Segars, D. Coppola, S. Mane, G.D. Wilbanks, W.F. O'Brien, and W.N. Spellacy Insights from gene arrays on the development and growth regulation of uterine leiomyomata Fertil Steril 78 2002 114 121
222. S.S. Palmer, D. Haynes-Johnson, T. Diehl, and R.A. Nowak Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compare with myometrium J Soc Gynecol Invest 5 1998 203 209
223. K. Englund, B. Lindblom, K. Carlström, I. Gustavsson, P. Sjöblom, and A. Blanck Gene expression and tissue concentrations of IGF-1 in human myometrium and fibroids under different hormonal conditions Mol Hum Reprod 6 2000 915 920
224. I. Gustavsson, K. Englund, M. Faxén, P. Sjöblom, B. Lindblom, and A. Blanck Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium Mol Hum Reprod 6 2000 55 59
225. C.A. Pambuccian, G.M. Oprea, and D.J. Lakatua Reduced expression of early growth response-1 gene in leiomyoma as identified by mRNA differential display Gynecol Oncol 84 2002 431 436
226. L.T. Van der Ven, P.J. Roholl, T. Gloudemans, S.C. Buul-Offers, M.J. Welters, B.A. Bladergroen, J.A. Faber, J.S. Sussenbach, and W. Den Otter Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues Br J Cancer 75 1997 1631 1640
227. M. Uzumcu, M.F. Homsi, D.K. Ball, S. Coskun, K. Jaroudi, J.M. Hollanders, and D.R. Brigstock Localization of connective tissue growth factor in human uterine tissues Mol Hum Reprod 6 2000 1093 1098
228. B.-S. Lee, and R.A. Nowak Human leiomyoma smooth muscle cells show increased expression of transforming growth factor -β3 (TGFβ3) and altered responses to the antiproliferative effects of TGFβ J Clin Endocrinol Metab 86 2001 913 920
229. D. Sampath, Y. Zhu, R.C. Winneker, and Z. Zhang Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17β-estradiol and basic fibroblast growth factor in human uterine leiomyomas J Clin Endocrinol Metab 86 2001 1707 1715
230. W.S. Ahn, K.W. Kim, S.M. Bae, J.H. Yoon, J.M. Lee, S.E. Namkoong, J.H. Kim, C.K. Kim, Y.J. Lee, and Y.W. Kim Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis Int J Exp Pathol 84 2003 267 279
231. N. Chegini, J. Verala, X. Luo, J. Xu, and R.S. Williams Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy J Soc Gynecol Invest 10 2003 161 171
232. W.H. Catherino, C. Prupas, J.C. Tsibris, P.C. Leppert, M. Payson, L.K. Nieman, and J.H. Segars Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology Fertil Steril 80 2003 282 290
233. H. Wang, M. Mahadevappa, K. Yamamoto, Y. Wen, B. Chen, J.A. Warrington, and M.L. Polan Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata Fertil Steril 80 2003 266 276
234. G. Weston, A.C. Trajstman, C.E. Gargett, U. Manuelpillai, B.J. Vollenhoven, and P.A. Rogers Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium Mol Hum Reprod 9 2003 541 549
235. B.J. Quade, T.-Y. Wang, K. Sornberger, P. Dal Cin, G.L. Mutter, and C.C. Morton Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling Genes Chromosomes Cancer 40 2004 97 108
236. J. Mollenhauer, S. Wiemann, W. Scheurlen, B. Korn, Y. Hayashi, K.K. Wilgenbus, A. von Deimling, and A. Poustka DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours Nat Genet 17 1997 32 39
237. P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K.A. Yung, H. Lin, A.H. Ligon, L.A. Langford, M.L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D.H.F. Teng, and S.V. Tavtigian Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 1997 356 362
238. S.D. Moore, S.R. Herrick, T.A. Ince, M.S. Kleinman, P. Dal Cin, C.C. Morton, and B.J. Quade Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF Cancer Res 64 2004 5570 5577
239. A.-K. Å]ström, M.L. Voz, K. Kas, E. Röijer, B. Wedell, N. Mandahl, W. Van de Ven, J. Mark, and G. Stenman Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene Cancer Res 59 1999 918 923
240. M.S. Rein, R.L. Barbieri, and A.J. Friedman Progesterone: a critical role in the pathogenesis of uterine myomas Am J Obstet Gynecol 172 1995 14 18
241. V. Stambolic, A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirstos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 29 39
242. P.I. Porter, A.M. Gown, S.J. Kramp, and M.D. Coltrera Widespread p53 overexpression in human malignant tumours. An immunohistochemical study using methacarn fixed, embedded tissue Am J Pathol 140 1992 145 153
243. Y. Soini, K. Vahakangast, K. Nuorva, D. Kamel, D. Lane, and P. Paakko p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours J Pathol 168 1992 29 33
244. M.D. Jeffers, M.A. Farquharson, J.A. Richmond, and M. McNicol p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus J Pathol 177 1995 65 70
245. T.H. Niemann, S.S. Raab, J.C. Lenel, J.R. Rodgers, and R.A. Robinson p53 protein overexpression in smooth muscle tumors of the uterus Hum Pathol 26 1995 375 379
246. Y.-L. Zhai, Y. Kobayashi, A. Mori, A. Orii, T. Nikaido, I. Konishi, and S. Fujii Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas Int J Gynecol Pathol 18 1999 20 28
247. K. Watanabe, T. Kusakabe, N. Hoshi, A. Saito, and T. Suzuki h-caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumors Hum Pathol 30 1999 392 396
248. M.R. Nucci, J.T. O'Connell, P.C. Huettner, A. Cviko, D. Sun, and B.J. Quade h-caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors Am J Surg Pathol 25 2001 455 463
249. S. Amada, H. Nakano, and M. Tsuneyoshi Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins Int J Gynecol Pathol 14 1995 134 142
250. A. Smits, K. Funa, F.S. Vassbotn, M. Beausang-Linder, F. af Ekenstam, C.-H. Heldin, B. Westermark, and M. Nistér Expression of platelet-derived growth factors and its receptors in proliferative disorders of fibroblastic origin Am J Pathol 140 1992 639 648
251. W. Trzyna, M. McHugh, P. McCue, and K.M. McHugh Molecular determination of the malignant potential of smooth muscle neoplasms Cancer 80 1997 211 217
252. S. Suster, C. Fisher, and C.A. Moran Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract Am J Surg Pathol 22 1998 863 872
253. A. Sourla, and M. Koutsilieris Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts J Clin Invest 96 1995 751 758
254. M. Shozu, H. Sumitani, T. Segawa, H.-J. Yang, K. Murakami, and M. Inoue Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate J Clin Endocrinol Metab 86 2001 5405 5411
255. Q. Dou, Y. Zhao, R.W. Tarnuzzer, H. Rong, R.S. Williams, G.S. Schultz, and N. Chegini Suppression of transforming growth factor-β (TGFβ) and TGFβ receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy J Clin Endocrinol Metab 81 1996 3222 3230
256. N. Chegini, J. Verala, X. Luo, J. Xu, and R.S. Williams Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy J Soc Gynecol Invest 10 2003 161 171
257. T. Noguchi, Y. Dobashi, H. Minehara, M. Itoman, and T. Kameya Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors Am J Pathol 156 2000 2135 2147
258. T. Gloudemans, I. Pospiech, L.T.M. Van Der Ven, C.J.M. Lips, H. Schneid, W. Den Otter, and J.S. Sussenbach Expression and CpG methylation of the insulin-like growth factor II gene in human smooth muscle tumors Cancer Res 52 1992 6516 6521
259. S. de Vos, S.P. Wilczynski, M.N. Fleischhacker, and P. Koeffler p53 alterations in uterine leiomyosarcomas versus leiomyomas Gynecol Oncol 54 1994 205 208
260. K.L. Hall, M.G. Teneriello, R.R. Taylor, S. Lemon, M. Ebina, R.I. Linnoila, J.H. Norris, R.C. Park, and M.J. Birrer Analyses of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas Gynecol Oncol 65 1997 330 335
261. C. Loddenkemper, S. Mechsner, H.-D. Foss, F.E. Dallenbach, I. Anagnostopoulos, A.D. Ebert, and H. Stein Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma Am J Surg Pathol 27 2003 1458 1462
262. T.H. Vu, C. Yballe, S. Boonyanit, and A.R. Hoffman Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata J Clin Endocrinol Metab 80 1995 1670 1676
263. B.J. Quade, A.P. Pinto, D.R. Howard, W.A. Peters III, and C.P. Crum Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma Am J Pathol 154 1999 95 150
264. P. Rogalla, C. Rohen, Y. Hennig, U. Deichert, U. Bonk, and J. Bullerdiek Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas Biochem Biophys Res Commun 211 1995 175 182
265. K. Vu, D.L. Greenspan, T.-C. Wu, H.A. Zacur, and R.J. Kurman Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas Hum Pathol 29 1998 359 363
266. J. Bullerdiek Leiomyoma-Do viruses play the main role? Genes Chromosomes Cancer 26 1999 181 183
267. M. Kiuru, V. Launonen, M. Hietala, K. Aittomäki, O. Vierimaa, R. Salovaara, J. Arola, E. Pukkala, P. Sistonen, R. Herva, and L.A. Aaltonen Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology Am J Pathol 159 2001 825 829
268. M. Kiuru, R. Lehtonen, J. Arola, R. Salovaara, H. Järvinen, K. Aittomäki, J. Sjöberg, T. Visakorpi, S. Knuutila, J. Isola, B. Delahunt, R. Herva, V. Launonen, A. Karhu, and L.A. Aaltonen Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families Cancer Res 62 2002 4554 4557
269. V. Launonen, O. Vierimaa, M. Kiuru, J. Isola, S. Roth, E. Pukkala, P. Sistonen, R. Herva, and L.A. Aaltonen Inherited susceptibility to uterine leiomyomas and renal cell cancer Proc Natl Acad Sci U S A 98 2001 3387 3392
270. N.A. Alam, S. Bevan, M. Churchman, E. Barclay, K. Barker, E.E.M. Jaeger, H.M. Nelson, E. Healy, A.C. Pembroke, P.S. Friedmann, K. Dalziel, E. Calonje, J. Anderson, P.J. August, M.G. Davies, R. Felix, C.S. Munro, M. Murdoch, J. Rendall, S. Kennedy, I.M. Leigh, D.P. Kelsell, I.P.M. Tomlinson, and R.S. Houlston Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43 Am J Hum Genet 68 2001 1264 1269
271. J.R. Toro, M.L. Nickerson, M.-H. Wei, M.B. Warren, G.M. Glenn, M.L. Turner, L. Stewart, P. Duray, O. Tourre, N. Sharma, P. Choyke, P. Stratton, M. Merino, M.M. Walther, W.M. Linehan, L. Schmidt, and B. Zbar Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America Am J Hum Genet 73 2003 95 106
272. K.L. Gross, C.I.M. Panhuysen, M.S. Kleinman, H. Goldhammer, E.S. Jones, N. Nassery, E.A. Stewart, and C.C. Morton Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: Genetic linkage analysis and FISH studies Genes Chromosomes Cancer 41 2004 183 190
273. I.P.M. Tomlinson, N.A. Alam, A.J. Rowan, E. Barclay, D. Kelsell, I. Leigh, P. Gorman, H. Lamlum, S. Rahman, R.R. Roylance, S. Olpin, S. Bevan, K. Barker, N. Hearle, R.S. Houlston, M. Kiuru, R. Lehtonen, A. Karhu, S. Vilkki, P. Laiho, C. Eklund, O. Vierimaa, K. Aittomäki, M. Hietala, P. Sistonen, A. Paetau, S. Salovaara, R. Herva, V. Launonen, and L.A. Aaltonen Germline mutations in the fumarate hydratase gene predispose to dominantly inherited uterine fibroids, skin leiomyomata and renal cell cancer Nat Genet 30 2002 406 410
274. P. Dal Cin, and C.C. Morton 1q42∼q44 is rarely cytogenetically involved in sporadic uterine leiomyomata Cancer Genet Cytogenet 138 2002 92 93
275. Hashimoto H, Quade B. Angioleiomyoma. WHO (World Health Organization) 2001; pp.128-9.
276. A. Vaillo-Vinagre, C. Ballestin-Carcavilla, S. Madero-Garcia, S. Pastor Garcia, A. Checa Garcia, and F.J. Martinez-Tello Primary angioleiomyoma of the iliac bone: clinical pathological study of one case with flow cytometric DNA content and S-phase fraction analysis Skeletal Radiol 29 2000 181 185
277. H. Nakayama, H. Enzan, E. Miyazaki, N. Kuroda, and M. Toi Lack of CD34 positive stromal cells within angiomyomas (vascular leiomyomas) J Clin Pathol 55 2002 395 396
278. S. Heim, N. Mandahl, U. Kristoffersson, F. Mitelman, B. Rööser, A. Rydholm, and H. Willén Structural chromosome aberrations in a case of angioleiomyoma Cancer Genet Cytogenet 20 1986 325 330
279. H. Sonobe, Y. Ohtsuki, H. Mizobuchi, M. Toda, and K. Shimizu An angiomyoma with t(X;10)(q22;q23.2) Cancer Genet Cytogenet 90 1996 54 56
280. Y. Hennig, J. Caselitz, C. Stern, S. Bartnitzke, and J. Bullerdiek Karyotype evolution in a case of uterine angioleiomyoma Cancer Genet Cytogenet 108 1999 79 80
281. M.R. Nucci, S. Weremowicz, G. Tallini, K. Sornberger, C.C. Morton, and B.J. Quade Chromosomal translocation t(8;12) indices aberrant HMGIC expression in aggressive angiomyxoma of the vulva Genes Chromosomes Cancer 32 2001 172 176
282. th ed. 2001 Mosby St. Louis
283. B.J. Quade, P. Dal Cin, D.M. Neskey, S. Weremowicz, and C.C. Morton Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case Mod Pathol 15 2002 351 356
284. J.P. Fryns, M. Haspeslagh, A. de Muelenaere, and H. Van den Berghe 9p trisomy/18p distal monosomy and multiple cutaneous leiomyomata: another specific chromosomal site (18pter) in dominantly inherited multiple tumors? Hum Genet 70 1985 284 286
285. M.P. Garcia Muret, R.M. Pujol, A. Alomar, J. Calaf, and J.M. de Moragas Familial leiomyomatosis cutis et uteri (Reed's syndrome) Arch Dermatol Res 280 1988 S29 S32
286. E.N. Meilahn, K.A. Matthews, G. Egeland, and S.F. Kelsey Characteristics of women with hysterectomy Maturitas 11 1989 319 329
287. K.H. Kjerulff, G.M. Guzinski, P.W. Langenberg, N.E. Adler Moye, and V.A. Kazandjian Hysterectomy and race Obstet Gynecol 82 1993 757 764
288. V.D.H. Winkler, and W. Hoffmann Regarding the question of inheritance of uterine myoma Deutsche-Medizinische Wochenschrift 68 1938 235 257
289. W.B. Reed, R. Walker, and R. Horowitz Cutaneous leiomyomata with uterine leiomyomata Acta Dermatovener (Stockholm) 53 1973 409 416
290. S.M. Schwartz Epidemiology of uterine leiomyomata Clin Obstet Gynecol 44 2001 316 326
291. E. Faerstein, M. Szklo, and N. Rosenshein Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking Am J Epidemiol 153 2001 1 10
292. M. Koorbanova, A.G. Koroleva, and A.S. Sergeyev Genetic-epidemiological analysis of myoma uteri: Estimate of recurrence risks Genetika 25 1989 1896 1898
293. M. Koorbanova, A.G. Koroleva, and A.S. Sergeyev Genetic analysis of the structure of liability to myoma uteri. Prevalence and morbidity Genetika 25 1989 1122 1124
294. L.M. Marshall, D. Spiegelman, J.E. Manson, M.B. Goldman, R.L. Barbieri, M.J. Stampfer, W.C. Willett, and D.J. Hunter Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking Epidemiology 9 1998 511 517
295. L.M. Marshall, D. Spiegelman, R.L. Barbieri, M.B. Goldman, J.E. Manson, G.A. Colditz, W.C. Willet, and D.J. Hunter Variation of the incidence of uterine leiomyomata among premenopausal women by age and race Obstet Gynecol 90 1998 967 973
296. K.H. Kjerulff, P. Langenberg, J.D. Seidman, P.D. Stolley, and G.M. Guzinski Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis J Reprod Med 41 1996 483 490
297. S.A. Treolar, N.G. Martin, L. Dennerstein, B. Raphael, and A.C. Heath Pathways to hysterectomy: Insights from longitudinal twin research Am J Obstet Gynecol 167 1992 82 88
298. F. Amant, M. Debiec-Rychter, E.F. Schoenmakers, A. Hagemeijer-Hausman, and I. Vergote Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome Genes Chromosomes Cancer 32 2001 324 329
299. T. Carsillo, A. Astrinidis, and E.P. Henske Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis Proc Natl Acad Sci U S A 97 2000 6085 6090
300. L. Heidet, E. Boye, and Y. Cai Somatic deletion of the 5′ ends of both COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus Am J Pathol 152 1998 673 678
301. Y. Ueki, I. Naito, T. Oohashi, M. Sugimoto, T. Seki, H. Yoshioka, Y. Sado, H. Sato, T. Sawai, F. Sasaki, M. Matsuoka, S. Fukuda, and Y. Ninomiya Topoiosomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome Am J Hum Genet 62 1998 253 261
302. J. Zhou, T. Mochizuki, H. Smeets, C. Antignac, P. Laurila, A. de Paepe, K. Tryggvason, and S.T. Reeders Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors Science 261 1993 1167 1169
303. M. Sarlomo-Rikala, W. El-Rifai, L. Andersson, M. Miettinen, and S. Knuutila Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas and schwannomas Hum Pathol 29 1998 476 481
304. C.C. Morton Genetic approaches to the study of uterine leiomyomata Environ Health Perspect 108 suppl 5 2000 775 778
305. M. Nilbert, S. Heim, N. Mandahl, U.-M. Flodérus, H. Willén, and F. Mitelman Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup Cancer Genet Cytogenet 45 1990 63 66
306. M. Nilbert, and B. Strömbeck Independent origin of uterine leiomyomas with karyotypically identical alterations Gynecol Obstet Invest 33 1992 246 248
307. F. Mugneret, S. Lizard-Nacol, C. Volk, J. Cuisenier, F. Colin, and C. Turc-Carel Association of breakpoint 14q23 with uterine leiomyoma Cancer Genet Cytogenet 34 1988 201 206
308. B. Kazmierczak, Y. Pohnke, and J. Bullerdiek Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations Genomics 38 1996 223 226
309. G. Tallini, R. Vanni, G. Manfioletti, B. Kazmierczak, G. Faa, P. Pauwels, J. Bullerdiek, V. Giancotti, H. Van den Berghe, and P. Dal Cin HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangements of the HMGI-C and HMGI(Y) genes Lab Invest 80 2000 359 369
310. R.A. Nowak Identification of new therapies for leiomyomas: What in vitro studies can tell us Clin Obstet Gynecol 44 2001 327 334
311. H. Wang, X. Wu, K. Englund, B. Masironi, H. Eriksson, and L. Sahlin Different expression of estrogen receptors α and β in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment Gynecol Endocrinol 15 2000 443 452
312. A.H. Ligon, and C.C. Morton Leiomyomata: heritability and cytogenetic studies Hum Reprod Update 7 2001 8 14
313. J.A. Fletcher, C.C. Morton, K. Pavelka, and J.M. Lage Chromosome aberrations in uterine smooth muscle tumors: Potential diagnostic relevance of cytogenetic instability Cancer Res 50 1990 4092 4097
314. G. Bardi, B. Johansson, N. Pandis, S. Heim, N. Mandahl, E. Bak-Jensen, H. Frederiksen, A. Andrén-Sandberg, and F. Mitelman Recurrent chromosome aberrations in abdominal smooth muscle tumors Cancer Genet Cytogenet 62 1992 43 46
315. T.-H. Bui, and L. Iselius t(7;22)(q31;q12) in a uterine leiomyoma Cancer Genet Cytogenet 59 1992 219
316. S.K. Fotiou, A.J. Tserkezoglou, H. Mahera, A.E. Konstandinidou, N.J. Agnantis, N. Pandis, and G. Bardi Chromosome aberrations and expression of ras and myc oncogenes in leiomyomas and a leiomyosarcoma of the uterus Eur J Gynaecol Oncol 13 1992 340 345
317. J. Hu, U. Surti, and H. Tobon Cytogenetic analysis of a uterine lipoleiomyoma Cancer Genet Cytogenet 62 1992 200 202
318. C. Stern, U. Deichert, B. Thode, S. Bartnitzke, and J. Bullerdiek Cytogenetic subtyping of 139 uterine leiomyoma Geburtshilfe Frauenheilkd 52 1992 767 772
319. Y.Y. Ozisik, A.M. Meloni, U. Surti, A. Peier, O. Altungöz, and A.A. Sandberg Cytogenetic findings in 101 uterine leiomyomas Turkish J Cancer 25 1995 5 14
320. G. Havel, R. Dahlenfors, B. Wedell, L. Hogström, and J. Mark Cytogenetical observations and hormone receptor expression in five extra-uterine leiomyomas Anticancer Res 14 1994 1935 1938
321. C. Karaiskos, N. Pandis, G. Bardi, K. Sfikas, A. Tserkezoglou, S. Fotiou, and S. Heim Cytogenetic findings in uterine epithelioid leiomyomas Cancer Genet Cytogenet 80 1995 103 106
322. K.L. Kingsley, A.M. Meloni, A.M. Peier, A.A. Sandberg, and U. Surti Deletion of both chromosome 7 homologues in leiomyoma Cancer Genet Cytogenet 81 1995 99 100
323. R. Dahlenfors, G. Havel, B. Wedell, and J. Mark Cytogenetics of parametrial leiomyoma Anticancer Res 17 1997 2121 2122
324. P. Dal Cin, B.J. Quade, S. Weremowicz, C.C. Morton, P. Pauwels, C. Ziekenhuis, and H. Van den Berghe Primary parauterine leiomyomata with a t(6;14) Genes Chromosomes Cancer 26 1999 385 386
325. M.S. Mantovani, J.B. Neto, P.M. Philbert, and C. Casartelli Multiple uterine leiomyomas: cytogenetic analysis Gynecol Oncol 72 1999 71 75
326. I. Van den Berghe, P. Dal Cin, R. Sciot, J. Vanvuchelen, P. Michielssen, A. Hagemeijer, L. De Baene, and H. Van den Berghe Translocation (4;8) as a primary chromosome change in a hydropic leiomyoma Histopathology 34 1999 378
327. Mitelman Database of Chromosome Aberrations in Cancer. Mitelman F, Johansson B, Mertens F, editors. Available at: http://cgap.nci.nih.gov/ Chromosomes/Mitelman. Accessed 2004.
328. M. Nilbert, N. Mandahl, S. Heim, A. Rydholm, H. Willén, and F. Mitelman Cytogenetic abnormalities in an angioleiomyoma Cancer Genet Cytogenet 37 1989 61 64